General Anesthesia Versus Sedation During Intra-arterial Treatment for Stroke

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 351 participants.

Also called NCT02822144

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 351 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02822144
  • EudraCT 2016-000795-25
Other papers using this trial's data
  • General Anesthesia versus Sedation, Both with Hemodynamic Control, during Intraarterial Treatment for Stroke: The GASS Randomized Trial Anesthesiology, 2022-04-01 DOI, PubMed 35226737

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
France (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02822144. Randomized; single masking; primary purpose treatment. Start 2016-09-29 (actual); primary completion 2020-08 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
General Anesthesia Versus Sedation During Intra-arterial Treatment for Stroke
Acronym
GASS
Condition
Stroke
Intervention (Drug)
Etomidate
Intervention (Drug)
Succinylcholine
Intervention (Drug)
Propofol
Intervention (Drug)
Remifentanil
Intervention (Drug)
Lidocaine
Lead sponsor
Rennes University Hospital (class: other)

Record details

Record id
cardio:ct-nct02822144
Content hash
2f4cc4734dfdd1e1bd77c409161e30c50b028e58372a519c4fe2783de04be534